Welcome to the Use of Valsartan/Sacubitril in Heart Failure with Reduced Ejection Fraction Pre Activity assessment.
Thank you and congratulations for attending this educational activity. Remember, continuous professional development is key to success and professional excellence.
Thank you
use of Entresto in HFrEF pre
Quiz Summary
0 of 4 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 4 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
| Average score |
|
| Your score |
|
Categories
- Not categorized 0%
-
Thank you for taking part in this educational activity. Please make sure you filled the Survey from the link above
- 1
- 2
- 3
- 4
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 4
1. Question
1 point(s)Sacubitril is a prodrug that inhibits neprilysin (a neutral endopeptidase) leading to increased levels of several endogenous vasoactive peptides, including:
-
Question 2 of 4
2. Question
1 point(s)Which of the following statements is correct:
-
Question 3 of 4
3. Question
1 point(s)Which of the following statements is correct:
-
Question 4 of 4
4. Question
1 point(s)Which of the following is an adverse effect of valsartan-sacubitril: